Time-resolved single-step protease activity quantification using nanoplasmonic resonator sensors.

Protease activity measurement has broad application in drug screening, diagnosis and disease staging, and molecular profiling. However, conventional immunopeptidemetric assays (IMPA) exhibit low fluorescence signal-to-noise ratios, preventing reliable measurements at lower concentrations in the clinically important picomolar to nanomolar range. Here, we demonstrated a highly sensitive measurement of protease activity using a nanoplasmonic resonator (NPR). NPRs enhance Raman signals by 6.1 x 10(10) times in a highly reproducible manner, enabling fast detection of proteolytically active prostate-specific antigen (paPSA) activities in real-time, at a sensitivity level of 6 pM (0.2 ng/mL) with a dynamic range of 3 orders of magnitude. Experiments on extracellular fluid (ECF) from the paPSA-positive cells demonstrate specific detection in a complex biofluid background. This method offers a fast, sensitive, accurate, and one-step approach to detect the proteases' activities in very small sample volumes.

[1]  R. V. Van Duyne,et al.  A glucose biosensor based on surface-enhanced Raman scattering: improved partition layer, temporal stability, reversibility, and resistance to serum protein interference. , 2004, Analytical chemistry.

[2]  Steven R. Emory,et al.  Probing Single Molecules and Single Nanoparticles by Surface-Enhanced Raman Scattering , 1997, Science.

[3]  J. Isaacs,et al.  A history of prostate cancer treatment , 2002, Nature Reviews Cancer.

[4]  Laurie L. Wood,et al.  New biochip technology for label-free detection of pathogens and their toxins. , 2003, Journal of microbiological methods.

[5]  Pablo G. Etchegoin,et al.  Surface Enhanced Raman Scattering Enhancement Factors: A Comprehensive Study , 2007 .

[6]  A. Kratz,et al.  Prostate-specific antigen and the early diagnosis of prostate cancer. , 2002, American journal of clinical pathology.

[7]  Henrik Grönberg,et al.  Prostate cancer epidemiology , 2003, The Lancet.

[8]  P. Hildebrandt,et al.  Surface-enhanced resonance Raman spectroscopy of Rhodamine 6G adsorbed on colloidal silver , 1984 .

[9]  N. Shah,et al.  Surface-enhanced Raman spectroscopy. , 2008, Annual review of analytical chemistry.

[10]  J. Janni,et al.  Surface-enhanced raman detection of 2,4-dinitrotoluene impurity vapor as a marker to locate landmines. , 2000, Analytical chemistry.

[11]  M. Natan,et al.  Self-Assembled Metal Colloid Monolayers: An Approach to SERS Substrates , 1995, Science.

[12]  Michael S. Feld,et al.  SURFACE-ENHANCED RAMAN SCATTERING : A NEW TOOL FOR BIOMEDICAL SPECTROSCOPY , 1999 .

[13]  Alan W Partin,et al.  PSA markers in prostate cancer detection. , 2003, The Urologic clinics of North America.

[14]  M. Wabuyele,et al.  Surface-enhanced Raman scattering for medical diagnostics and biological imaging , 2005 .

[15]  H. Lilja,et al.  Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen. , 1997, Cancer research.

[16]  S. Shariat,et al.  Molecular diagnosis of prostate cancer , 2004 .

[17]  J. Isaacs,et al.  The role of prostate‐specific antigen in the clinical evaluation of prostatic disease , 2004, BJU international.

[18]  Christy L. Haynes,et al.  Plasmon-Sampled Surface-Enhanced Raman Excitation Spectroscopy † , 2003 .

[19]  U. Stenman,et al.  Immunopeptidometric assay for enzymatically active prostate-specific antigen. , 2004, Clinical chemistry.

[20]  K. Nakamoto,et al.  Introductory Raman Spectroscopy , 1994 .

[21]  C. Mirkin,et al.  Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. , 2002, Science.

[22]  J. Clements,et al.  The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers , 2004, Critical reviews in clinical laboratory sciences.

[23]  Kasem Nithipatikom,et al.  Characterization and application of Raman labels for confocal Raman microspectroscopic detection of cellular proteins in single cells. , 2003, Analytical biochemistry.

[24]  A. Haese*,et al.  Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer , 2004 .

[25]  Olga Lyandres,et al.  Real-time glucose sensing by surface-enhanced Raman spectroscopy in bovine plasma facilitated by a mixed decanethiol/mercaptohexanol partition layer. , 2005, Analytical chemistry.

[26]  H. Lilja,et al.  Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. , 2003, Journal of the National Cancer Institute.

[27]  M. Moskovits Surface-enhanced spectroscopy , 1985 .

[28]  Chad A Mirkin,et al.  Raman dye-labeled nanoparticle probes for proteins. , 2003, Journal of the American Chemical Society.

[29]  D. A. Stuart,et al.  Surface-enhanced Raman spectroscopy of half-mustard agent. , 2006, The Analyst.

[30]  U. Stenman,et al.  Separation of enzymatically active and inactive prostate‐specific antigen (PSA) by peptide affinity chromatography , 2004, The Prostate.

[31]  Edgar Voges,et al.  Periodically structured metallic substrates for SERS , 1998 .

[32]  N J Halas,et al.  Surface-enhanced Raman scattering on tunable plasmonic nanoparticle substrates , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Yi Xiong,et al.  Raman enhancement factor of a single tunable nanoplasmonic resonator. , 2006, The journal of physical chemistry. B.

[34]  Tuan Vo-Dinh,et al.  Surface-enhanced Raman Scattering (SERS) method and instrumentation for genomics and biomedical analysis , 1999 .